| Literature DB >> 28337319 |
Elisa Nuti1, Lea Rosalia1, Doretta Cuffaro1, Caterina Camodeca1, Chiara Giacomelli1, Eleonora Da Pozzo1, Tiziano Tuccinardi1, Barbara Costa1, Claudia Antoni2, Laura Vera3, Lidia Ciccone1, Elisabetta Orlandini1, Susanna Nencetti1, Vincent Dive3, Claudia Martini1, Enrico A Stura3, Armando Rossello1.
Abstract
Protein homodimers play important roles in physiological and pathological processes, including cancer invasion and metastasis. Recently, MMP-9 natural homodimerization via the PEX domain has been correlated with high migration rates of aggressive cancer cells. Here we propose that bifunctional MMP-9 inhibitors designed to impair natural MMP-9 homodimerization promoted by PEX-PEX interactions might be an effective tool to fight cancer cell invasion. Elaborating a previously described dimeric hydroxamate inhibitor 1, new ligands were synthesized with different linker lengths and branch points. Evaluation of the modified bifunctional ligands by X-ray crystallography and biological assays showed that 7 and 8 could reduce invasion in three glioma cell lines expressing MMP-9 at different levels. To rationalize these results, we present a theoretical model of full-length MMP-9 in complex with 7. This pioneering study suggests that a new approach using MMP-9 selective bifunctional inhibitors might lead to an effective therapy to reduce cancer cell invasion.Entities:
Keywords: Bifunctional inhibitors; MMP-9 homodimerization; X-ray crystallography; glioblastoma multiforme
Year: 2017 PMID: 28337319 PMCID: PMC5346986 DOI: 10.1021/acsmedchemlett.6b00446
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345